Results 261 to 270 of about 104,119 (333)

NeoThy™ immune-humanized mice can produce anti-drug antibodies to support immunogenicity assessment for biological drug products. [PDF]

open access: yesFront Immunol
Gharaie S   +10 more
europepmc   +1 more source

KLF15 as a Metabolic Gatekeeper Linking Drug Metabolism, Toxicity, and Precision Therapeutics

open access: yesiNew Medicine, EarlyView.
KLF15‐mediated metabolic preconditioning links metabolic state to drug disposition, therapeutic efficacy, and adverse effects, extending classical xenobiotic sensing toward precision pharmacology. ABSTRACT Krüppel‐like factor 15 (KLF15) is emerging as a metabolic‐state‐sensitive regulator of hepatic endobiotic and xenobiotic metabolism.
Shilin Li   +3 more
wiley   +1 more source

Translatable electrophysiological and behavioral abnormalities in a humanized model of SYNGAP1-disorder. [PDF]

open access: yesMol Psychiatry
Felix AJ   +16 more
europepmc   +1 more source

Hepatocyte‐Centered Regulation of MASH Fibrosis: From Animal Models to Molecular Mechanisms and Targeted Therapies

open access: yesiNew Medicine, EarlyView.
This review highlights hepatocytes as active regulators of MASH fibrosis through secreted proteins, metabolites, and extracellular vesicles that modulate hepatic stellate cell activation. These hepatocyte–stellate cell communication pathways provide a mechanistic framework for developing targeted antifibrotic therapies, including hepatocyte‐directed ...
Eui Jung Jung, Xiaobo Wang
wiley   +1 more source

Mice with humanized FXR ligand-binding domain display distinct metabolic responses upon pharmacological FXR stimulation. [PDF]

open access: yesJ Lipid Res
Li J   +16 more
europepmc   +1 more source

Exploring the immune environment of glioblastoma in humanized mouse models. [PDF]

open access: yesNeuro Oncol
Takei J   +12 more
europepmc   +1 more source

Recovery-oriented practices as a pathway toward advancing mental healthcare in Brazil. [PDF]

open access: yesCad Saude Publica
Souza LM   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy